Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-09

Clinical Trial Update: A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating LY4167586 in adults who are overweight or obese but otherwise healthy; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY4167586

Snippet

Sponsor: Eli Lilly and Company | Conditions: Overweight, Obesity | Phase 1 | Status: RECRUITING